TSXV:APC.H - Post Discussion
Post by
Betteryear2 on Apr 13, 2022 10:15pm
Advanced Proteome Therapeutics Receives Notice of Allowance
Vancouver, British Columbia--(Newsfile Corp. - April 13, 2022) - Advanced Proteome Therapeutics Corporation (TSXV: APC) (FSE: 0E8) ("APC" or the "Company") is pleased to announce that its US subsidiary, Advanced Proteome Therapeutics Inc. ("APTI") has received a notice of allowance for patent claims covering key intellectual property. Advanced Proteome Therapeutics Receives Notice of Allowance for Patent Claims
Be the first to comment on this post